Clinical Trial

xDot Access Management System Early Feasibility Study

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to demonstrate safety and investigate effectiveness of the xDot Access Management System (AMS) for closure of large bore femoral-arterial and femoral-venous access sites.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-07
notable Trial sites expanded: 0 -> 3 locations 2026-07-07
Trial Details
NCT Number NCT07464353
Lead Sponsor xDot Medical, Inc
Collaborators: Bright Research Partners
Conditions Vascular Closure Devices
Enrollment 30 participants
Start Date 2026-06-16
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-06